Darolutamide performs well across subgroups in mHSPC Presented ByProf. Bertrand Tombal, Université Catholique de Louvain, Belgium TrialPhase 3, ARASENS ConferenceEAU 2022 22 July, 2022 12:33
Does systematic biopsy add value to the detection rate of prostate cancer? Presented ByDr Enrico Checcucci, University of Turin, Italy ConferenceEAU 2022 22 July, 2022 12:42
PSMA PET/CT cannot replace mpMRI for diagnosis of prostate cancer Presented ByProf. Lih-Ming Wong, University of Melbourne, Australia TrialPhase 3 ConferenceEAU 2022 22 July, 2022 12:41
Prostate cancer treatments reduce quality of life Presented ByMr André Deschamps, Europa Uomo, Belgium TrialEUPROMS 2.0 ConferenceEAU 2022 22 July, 2022 12:39
PROpel: Good results for abiraterone plus olaparib in mCRPC Presented ByProf. Noel Clarke, University of Manchester, UK TrialPhase 3, PROpel ConferenceEAU 2022 22 July, 2022 12:37
Neoadjuvant hormonal therapy promising in high-risk prostate cancer Presented ByProf. Steven Joniau, UZ Leuven, Belgium TrialPhase 2, ARNEO ConferenceEAU 2022 22 July, 2022 12:35
Darolutamide performs well across subgroups in mHSPC Presented ByProf. Bertrand Tombal, Université Catholique de Louvain, Belgium TrialPhase 3, ARASENS ConferenceEAU 2022 22 July, 2022 12:33
Shorter hospital stay with robotic surgery versus open surgery in bladder cancer Presented ByProf. James Catto, University of Sheffield, UK TrialPhase 3, iROC ConferenceEAU 2022 22 July, 2022 12:30
Improved risk stratification for high-risk NMIBC Presented ByMr Florus de Jong, Erasmus University Medical Center, the Netherlands ConferenceEAU 2022 22 July, 2022 12:28
Adjuvant atezolizumab may benefit ctDNA-positive patients with post-op muscle-invasive urothelial carcinoma Presented ByProf. Jürgen Gschwend, Technical University Munich, Germany TrialPhase 3, IMvigor010 ConferenceEAU 2022 22 July, 2022 12:26
New prognostication in N3 penile cancer Presented ByDr James Churchill, St George Hospital, Australia ConferenceEAU 2022 22 July, 2022 12:24
KEYNOTE-564: Updated results of adjuvant pembrolizumab in RCC Presented ByProf. Thomas Powles, Barts Cancer Institute, UK TrialPhase 3, KEYNOTE-564 ConferenceEAU 2022 22 July, 2022 12:22
Fewer complications with robotic surgery in renal cancer Presented ByProf. Marc-Oliver Grimm, Universitätsklinikum Jena, Germany TrialPhase 3, OpeRa ConferenceEAU 2022 22 July, 2022 12:19
Novel therapeutic targets for benign prostatic hyperplasia Presented ByProf. Richard Bryant, University of Oxford, UK ConferenceEAU 2022 22 July, 2022 12:17
Mini-slings non-inferior to standard mid-urethral slings in SUI Presented ByProf. Mohamed Abdel-fattah, University of Aberdeen, UK TrialSIMS ConferenceEAU 2022 22 July, 2022 12:14
Non-inferiority of methenamine hippurate to antibiotics in recurrent UTIs Presented ByProf. Christopher Harding, Newcastle University, UK TrialALTAR ConferenceEAU 2022 22 July, 2022 12:02